Sundance Pharmaceuticals is developing cannabis pharmaceutical drugs for major illnesses that are to be available in all states and Canada and covered by medical insurance.

Versions of the pharmaceutical drugs with the same proven high quality and reliability are being developed for the self-care natural products market in the 33 states where legalized and in Canada.

Sundance is preparing to conduct clinical trials for U.S. Food and Drug Administration and Health Canada approvals for prevention and treatment of COVID-19 and treatment for rheumatoid arthritis, acute pain, opioid dependence, traumatic brain injury and quality of life in lung and colon cancer.